salvicin

a biocyclic diterpenoid; ensures the preservation of islet beta-cells in animals with alloxan diabetes

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Hyperglycemia 01/01/1992 - "Biocyclic diterpenoids--salvin, salvicin and salvifolin, administered per os to rats at a dose of 50 mg/kg show marked hypoglycemic activity in intact animals as well as in animals with experimental hyperglycemia developing against a background of GTT (3000 mg/kg intraperitoneally) or alloxan (150 mg/kg subcutaneously). "

1.	Hypoglycemic Agents (Hypoglycemics)
2.	Diterpenes
3.	Alloxan
4.	salvipholin
5.	salvin